GENEWERK

genewerk-logo

GeneWerk GmbH was founded in July 2014 by Prof. Dr. Christof von Kalle, Dr. Manfred Schmidt and Dr. Annette Deichmann with participation of the German Cancer Research Center (DKFZ) Heidelberg. their team has long lasting experience in the area of integration site analysis, high throughput sequencing, whole genome sequencing and bioinformatics. It is very innovative in developing new analysis methods โ€“ perhaps also for your project?

#SimilarOrganizations #Website #More

GENEWERK

Social Links:

Industry:
Biotechnology Health Care

Founded:
2014-07-01

Address:
Heidelberg, Baden-Wurttemberg, Germany

Country:
Germany

Website Url:
http://www.genewerk.com

Total Employee:
11+

Status:
Active

Contact:
+49 6221 42790-0

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress


Similar Organizations

avacta-animal-health-logo

Avacta Animal Health

Avacta Animal Health is an veterinary laboratory service provider and diagnostic tester to surgeons, laboratories on animal allergies.

nupotential-logo

NuPotential

NuPotential produces cell lines suitable for re-differentiation into multiple lineages and somatic cell nuclear transfers.

Official Site Inspections

http://www.genewerk.com Semrush global rank: 8.19 M Semrush visits lastest month: 354

  • Host name: 217-160-0-20.elastic-ssl.ui-r.com
  • IP address: 217.160.0.20
  • Location: Germany
  • Latitude: 51.2993
  • Longitude: 9.491
  • Timezone: Europe/Berlin

Loading ...

More informations about "GeneWerk"

GeneWerk - Crunchbase Company Profile & Funding

GeneWerk GmbH was founded in July 2014 by Prof. Dr. Christof von Kalle, Dr. Manfred Schmidt and Dr. Annette Deichmann with participation of the German Cancer Research Center (DKFZ) โ€ฆSee details»

The Management - Genewerk

Dr. Annette Deichmann Annette Deichmann. Annette Deichmann is shareholder and Managing Director of the start-up company GeneWerk GmbH founded in 2014. As biologist she got the โ€ฆSee details»

About us - Genewerk

GeneWerk GmbH was founded in July 2014 by Prof. Dr. Christof von Kalle, Dr. Manfred Schmidt and Dr. Annette Deichmann with participation of the German Cancer Research Center (DKFZ) โ€ฆSee details»

Protagen Protein Services merges with GeneWerk to integrate โ€ฆ

Jul 21, 2001 The combined organization will have more than 175 employees across four sites in Europe and North America. โ€œThe combination of Protagen Protein Services (PPS) and โ€ฆSee details»

About, History & Values - ProtaGene

In 2021, GeneWerkโ€™s unique capabilities in vector safety, integration site analysis, and bioinformatics were added to our portfolio, ... The organization operates four sites in Europe โ€ฆSee details»

GeneWerk - Products, Competitors, Financials, Employees, โ€ฆ

GeneWerk provides platforms and bioinformatics to determine fusion sequences adjacent to known DNA or RNA fragments in minimal tissue samples down to the single-cell level. On โ€ฆSee details»

Protagen Protein Services Merges with GeneWerk to Integrate โ€ฆ

Jul 1, 2021 With the addition of GeneWerk's unique capabilities in vector safety, characterization, and functionality analysis, PPS will complement its current analytical testing โ€ฆSee details»

Protagen Protein Services Merges with GeneWerk to Integrate

Jul 1, 2021 The combined organization will have more than 175 employees across four sites in Europe and North America. โ€œThe combination of Protagen Protein Services (PPS) and โ€ฆSee details»

GeneWerk Company Profile - Office Locations, Competitors ... - Craft

GeneWerk is a company that provides platforms and bioinformatics to determine fusion sequences adjacent to known DNA or RNA fragments in minimal tissue samples down to the โ€ฆSee details»

ProtaGene acquires GeneWerk - 2021-07-01 - Crunchbase

Jul 1, 2021 GeneWerk GeneWerk GmbH provides highly sensitive platforms and bioinformatics to determine fusion sequences adjacent to known DNA or RNA fragments. Acquiring โ€ฆSee details»

GeneWerk (GeneWerk GmbH) - Startbase

Legal Entity: GeneWerk GmbH Location: Baden-Württemberg Overview Company Funding Product Team News Is this your company? Profile is not claimed et. This profile is created by โ€ฆSee details»

Protagen, BioAnalytix, and GeneWerk unveil combined CRO โ€ฆ

Jan 13, 2022 Protagen, BioAnalytix, and GeneWerk this week announced their unified operations and re-brand as ProtaGene, a CRO partner for the biologics and cell and gene โ€ฆSee details»

Ampersand Capital Partners acquires GeneWerk - Crunchbase

GeneWerk GeneWerk GmbH provides highly sensitive platforms and bioinformatics to determine fusion sequences adjacent to known DNA or RNA fragments. Acquiring Organization: โ€ฆSee details»

Protagen Protein Services merges with GeneWerk - Manufacturing โ€ฆ

Jul 2, 2021 Protagen Protein Services (PPS) has announced it will merge with GeneWerk, an Ampersand portfolio company. With the addition of GeneWerkโ€™s unique capabilities in vector โ€ฆSee details»

Ampersand Portfolio Company GeneWerk Acquires Protagen โ€ฆ

Jul 12, 2021 A cross-border Private Equity and Healthcare team advised GeneWerk on its merger with Protagen Protein Services.. GeneWerk, an Ampersand portfolio company, is a cell โ€ฆSee details»

Start - GeneWerk

Hochauflösende Analyse-Plattform für DNA- oder RNA-Fusionssequenzen. Hochsensitive Analyseplattformen der GeneWerk GmbH ermöglichen die Bestimmung und projektspezifische โ€ฆSee details»

News - Genewerk

GeneWerk Announces Growth Equity Investment from Ampersand Capital Partners. Insight into Spatial and Temporal Trends of SARS-CoVโ€‘2 Infection Outbreak. am: 20-06-04 12:32 by:See details»

GeneWerk Announces Growth Equity Investment from Ampersand โ€ฆ

GeneWerk will expand capabilities to meet rapidly growing demand for cell and gene therapy testing services. GeneWerk GmbH, a cell and gene therapy testing laboratory focused on โ€ฆSee details»

Vector Safety - Genewerk

Vector Safety. The application of viral vectors in gene therapy is rapidly developing and the therapeutic results are highly promising. Actively and passively integrating (viral) vectors may โ€ฆSee details»

linkstock.net © 2022. All rights reserved